Bioinspired by tunicates and mussels, a Korean research team has created a “bomb-like” anticancer therapeutic agent that only destroys cancer cells.
The nanobomb produces heat in precise sites where near-IR (NIR) laser is irradiated to create nitric oxide gas, which has an anticancer effect and concurrently discharges anticancer drugs to accomplish the trimodal treatment of photothermal-gas-chemo-therapy.
The POSTECH research team was headed by Professor Hyung Joon Cha and Dr. Yeonsu Jeong (Department of Chemical Engineering) in partnership with Professor Yun Kee Jo’s team at Kyungpook National University (Department of Biomedical Convergence Science and Technology, School of Convergence).
The researchers engineered a photoactivatable adhesive nanobomb with mussel adhesive proteins (MAPs) and the catechol-vanadium complex of tunicates that involves light-associated energy conversion through electron transfer. The term ‘photoactivatable’ denotes the characteristic where properties vary based on the external light.
Since cancer manifests via multiple biological pathways, a process that integrates several treatments rather than one single treatment is generally employed. But it is challenging to deliver several therapeutic agents at once to a particular cancer site because of the large amount of fluid found in the human body.
Among such approaches, light-triggered photothermal therapy (PTT) employs nanoparticles of metals, synthetic polymers or carbon. However, their weak biodegradability, which can cause a hazard of systemic toxicity, and low photothermal conversion efficiency — the efficiency at which the captured light is turned to heat — render effective cancer treatment tough.
To this, the researchers developed nanoparticles by incorporating the catechol-vanadium complexes — which help electrons and light travel in tunicates — to the MAP. When these nanoparticles are exposed to the light from NIR lasers, the temperature can be increased to 50 degrees within 5 minutes, displaying exceptional photothermal conversion efficiency of around 50%.
These nanoparticles can be retained on cancer cells for an extended period owing to the robust adhesiveness of MAP. Furthermore, the excellent biocompatibility and biodegradability of proteinic nanoparticles resolve the safety matter of traditional light-responsive nanotherapeutics.
When the nanoparticles comprising a thermo-sensitive nitric oxide (NO) donor and an anticancer drug were irradiated using the near-IR (NIR) laser, NO gas and drugs were effectively discharged due to the photothermal effect, verifying their likelihood for use in a nanobomb.
It is generally tough to retain the anticancer effects of NO gas as it rapidly biometabolizes. However, the nanobomb can regulate the release of gas with light, which significantly raises the delivery efficiency of NO.
In preclinical testing in animal models, the tumor grew back 15 days after being treated with only a single photothemal treatment, whereas the therapeutic effectiveness was extended with trimodal treatments using nanobombs as no tumors were seen for around 1 month.
With a single nanoparticle, various site-specific therapeutic agents can be locally administered and multimodal treatments can be easily controlled with a single stimulus, which will be effective in treating cancer patients in the future.
Professor Hyung Joon Cha, Department of Chemical Engineering, Pohang University of Science and Technology
“This nanobomb can be applied not only to photothermal-gas-chemo-therapy, but also to the delivery of therapeutics including genes and antibodies or contrast agents, and therefore can be widely used according to the specific needs of the patient or the condition,” Professor Hyung Joon Cha added.
This research was chosen as the front cover paper of the December issue of Advanced Healthcare Materials, a well-known journal in the domain of materials science.
The research was performed with the support from the National Research Foundation grant funded by the Ministry of Science and ICT of Korea, the National Research Foundation grant funded by the Ministry of Education of Korea, and the Marine BioMaterials Research Center grant funded by the Ministry of Oceans and Fisheries of Korea.
The mussel adhesive protein technology has gone through a technology transfer to Nature Glutech Co., Ltd., and clinical trials will take place after procuring investigational new drug (IND) approvals.
News
One Nasal Spray Could Protect Against COVID, Flu, Pneumonia, and More
A single nasal spray vaccine may one day protect against viruses, pneumonia, and even allergies. For decades, scientists have dreamed of creating a universal vaccine capable of protecting against many different pathogens. The idea [...]
New AI Model Predicts Cancer Spread With Incredible Accuracy
Scientists have developed an AI system that analyzes complex gene-expression signatures to estimate the likelihood that a tumor will spread. Why do some tumors spread throughout the body while others remain confined to their [...]
Scientists Discover DNA “Flips” That Supercharge Evolution
In Lake Malawi, hundreds of species of cichlid fish have evolved with astonishing speed, offering scientists a rare opportunity to study how biodiversity arises. Researchers have identified segments of “flipped” DNA that may allow fish to adapt rapidly [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Scientists Discover Why Some COVID Survivors Still Can’t Taste Food Years Later
A new study provides the first direct biological evidence explaining why some people continue to experience taste loss long after recovering from COVID-19. Researchers have uncovered specific biological changes in taste buds that could help [...]
Catching COVID significantly raises the risk of developing kidney disease, researchers find
Catching Covid significantly raises the risk of developing deadly kidney disease, research has shown. The virus was found to increase the chances that patients will develop the incurable condition by around 50 per cent. [...]
New Toothpaste Stops Gum Disease Without Harming Healthy Bacteria
Researchers have developed a targeted approach to combat periodontitis without disrupting the natural balance of the oral microbiome. The innovation could reshape how gum disease is treated while preserving beneficial bacteria. The human mouth [...]
Plastic Without End: Are We Polluting the Planet for Eternity?
The Kunming Montreal Global Biodiversity Framework calls for the elimination of plastic pollution by 2030. If that goal has been clearly set, why have meaningful measures that create real change still not been implemented? [...]
Scientists Rewire Natural Killer Cells To Attack Cancer Faster and Harder
Researchers tested new CAR designs in NK-92 cells and found the modified cells killed tumor cells more effectively, showing stronger anti-cancer activity. Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based [...]
New “Cellular” Target Could Transform How We Treat Alzheimer’s Disease
A new study from researchers highlights an unexpected player in Alzheimer’s disease: aging astrocytes. Senescent astrocytes have been identified as a major contributor to Alzheimer’s progression. The cells lose protective functions and fuel inflammation, particularly in [...]
Treating a Common Dental Infection… Effects That Extend Far Beyond the Mouth
Successful root canal treatment may help lower inflammation associated with heart disease and improve blood sugar and cholesterol levels. Treating an infected tooth with a successful root canal procedure may do more than relieve [...]
Microplastics found in prostate tumors in small study
In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. The findings — which come from a small study of 10 [...]
All blue-eyed people have this one thing in common
All Blue-Eyed People Have This One Thing In Common Blue Eyes Aren’t Random—Research Traces Them Back to One Prehistoric Human It sounds like a myth at first — something you’d hear in a folklore [...]
Scientists reveal how exercise protects the brain from Alzheimer’s
Researchers at UC San Francisco have identified a biological process that may explain why exercise sharpens thinking and memory. Their findings suggest that physical activity strengthens the brain's built in defense system, helping protect [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Deadly Pancreatic Cancer Found To “Wire Itself” Into the Body’s Nerves
A newly discovered link between pancreatic cancer and neural signaling reveals a promising drug target that slows tumor growth by blocking glutamate uptake. Pancreatic cancer is among the most deadly cancers, and scientists are [...]
